3.

组间和组内安全性比较

Comparison of safety between and within the two groups

Outcome indicators	Medication node	Group		P
		Test	Control
Creatinine (μmol/L)
	Before	60.50 (52.00, 83.25) 79.03%	59.00 (43.50, 69.75) 85.48%	0.133
	After	62.00 (52.78, 71.50) 87.10%	54.00 (41.25, 66.75) 87.10%	0.034
	P	0.730	0.217
Urea (mmol/L)
	Before	5.09 (3.49, 7.12) 62.90%	4.39 (3.67, 5.81) 83.87%	0.233
	After	4.49 (3.11, 6.22) 61.29%	4.56 (3.00, 6.05) 61.29%	0.509
	P	0.103	0.838
Cystatin C (mg/L)
	Before	1.46 (0.91, 2.01) 25.81%	1.27 (0.95, 1.70) 32.26%	0.500
	After	1.10 (0.78, 1.46) 45.16%	1.18 (1.00, 1.52) 35.48%	0.188
	P	0.032	0.386
Uric acid (μmol/L)
	Before	263.00 (175.00, 327.50) 72.58%	217.50 (151.75, 309.00) 66.13%	0.224
	After	211.00 (138.25, 320.25) 72.58%	175.50 (129.25, 290.25) 69.35%	0.318
	P	0.125	0.189